XmAb819 clinical trials

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

This study is looking into a new treatment called XmAb®819 for a type of kidney cancer called clear cell renal cell carcinoma. The main goals are to find out if it's safe, how well people tolerate it, and what the best dose is.